{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/652558c78b631000124f5568/69de219a2cab0d3ec87dacd6?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Episode 3: The evolving role of ultrasound in HS ","description":"<p>his&nbsp;podcast&nbsp;is aimed at healthcare professionals, produced and funded by UCB.&nbsp;&nbsp;</p><p><br></p><p>In episode 3, our host, Prof Monika&nbsp;Arenbergerová&nbsp;speaks with&nbsp;fellow&nbsp;ultrasound expert Prof Valentina Dini. Prof Dini tells us about how ultrasound works in HS,&nbsp;differentiating between&nbsp;different types&nbsp;of HS lesions with ultrasound, and&nbsp;how we can use the updated guidelines and ultrasound to optimise diagnosis.&nbsp;</p><p>HS: Hidradenitis Suppurativa&nbsp;</p><p><br></p><p><em>Prof Monika&nbsp;Arenbergerová&nbsp;has received support from UCB, AbbVie, and Novartis.</em>&nbsp;</p><p><br></p><p><em>Prof Valentina Dini has received support from&nbsp;AbbVie, Eli Lilly,&nbsp;Johnson &amp; Johnson, Sanofi,&nbsp;Convatec,&nbsp;Almirall ,&nbsp;Leo&nbsp;Pharma, UCB,&nbsp;Novartis ,&nbsp;Boehringer Ingelheim.</em>&nbsp;</p>","author_name":"UCB Biopharma"}